Navigation Links
Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer,Study Presented at ASCO

Of the ten patients evaluated, all ten patients completed four weeks, while seven of the ten patients completed eight weeks of therapy. Among the ten evaluable patients, there was one complete response (CR), one partial response (PR), and one patient with a 30% reduction in tumor volume.

Patients also underwent sequential biopsies of their tumors to evaluate biomarkers of hypoxia and angiogenesis. Paclitaxel causes an increase in tumor HIF-1alpha expression, which is downregulated by 2ME2. Changes were observed in HIF-1 regulated proteins, including tissue VEGF, VEGFR-2, plasma PAI-1, and osteopontin. Based on these findings, enrollment is continuing to further define the relationship between 2ME2 therapy and the effects on these biomarkers with the goal of identifying patients who would most benefit from 2ME2's unique mechanisms of action.

Carolyn F. Sidor, M.D., M.B.A, EntreMed Vice President and Chief Medical Officer, commented on the study, "Results to date are encouraging and further support EntreMed's rationale for using Panzem(R) NCD in combination with approved chemotherapeutics. Panzem(R) NCD's safety profile and lack of MDR chemoresistance offer opportunities for combining it with conventional chemotherapies to increase their effectiveness without increasing toxicity."

Dr. Sidor further commented, "Breast cancer remains a significant health problem, killing over 40,000 American women annually, despite the introduction of new therapies. A primary resistance mechanism to chemotherapeutic agents is thought to be the upregulation of HIF-1alpha and Panzem(R) is a potent inhibitor of HIF-1alpha. We hope that this study will also begin to identify biomarkers that we can use to further identify patients who would most benefit from treatment with Panzem(R) NCD."

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:11/22/2014)... NEWTOWN, Pennsylvania , 21 de noviembre de ... servicios de ensayos clínicos externalizados y tecnologías eClinical, ... su aproximación de ,seguimiento inteligente, para el seguimiento ... El seguimiento inteligente amplía el concepto del seguimiento ... simple reducción de las visitas de seguimiento o ...
(Date:11/22/2014)... 21, 2014  Particle Sciences, Inc (PSI), the ... and manufactured a new innovative vaginal ring for ... Development arm of Exeltis Pharmaceuticals.  According to ... at Particle Sciences, "This vaginal ring was developed ... sciences and modeling expertise.  We are thrilled it ...
(Date:11/21/2014)... PARK, Md. , Nov. 21, 2014  The ... today will host the ceremonial groundbreaking of the new ... College Park. The new building will cultivate transformative new ... health.  Taking place at 10:00 a.m. on ... in the Paint Branch Parking Lot, adjacent to the ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
(Date:11/24/2014)... Volpara Solutions announced today that it will ... Meeting of the Radiology Society of North America ... – South Hall). Volpara Solutions will showcase the ... its innovative suite of quantitative breast imaging tools, ... of volumetric density, patient-specific dose, breast compression and ...
(Date:11/24/2014)... 24, 2014 Recently, SweetDressy.com, a well-known ... its new collection of 2014 Evening Dresses. All these ... to the company’s marketing manager, the special offer is ... for more. , Sweetdressy.com has been working well in ... unveil the latest designs. Their new dresses may be ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 SafeHandles™ announced ... of Innovations with Ed Begley Jr, airing via Discovery ... created to provide a passive, non-invasive, replaceable, and affordable ... SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to promote ... , “At the core of SafeHandles is the desire ...
(Date:11/23/2014)... The clinical trial report, "Aspergillosis Global ... the Aspergillosis clinical trial scenario. This report provides ... trials on Aspergillosis. It includes an overview of ... per the site of trial conduction across the ... disease clinical trials by their phase, trial status, ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
Breaking Medicine News(10 mins):Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 2Health News:Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... Tube-Feeding Best-Practice Recommendations NEW ORLEANS, Feb. 3 ... HealthCare Nutrition and the American Society for Parenteral ... launch of a new initiative to promote safe ... designed to raise awareness of key steps that ...
... LEXINGTON, Ky., Feb. 3 Just because the economy isn,t ... a Valentine,s surprise for that,special someone. Now,s the time ... from discounted treatments to complimentary services. Roses wilt,and chocolates melt, ... not only a,romantic gift but a healthful one too. , ...
... out the bumps in aesthetic skin care with its latest offering. ... the UniForm handpiece, recently approved by the FDA for cellulite treatment. ... ... seeking painless cellulite treatment, New York City based Juva Skin and ...
... (February 2, 2009) New research published in the ... College of Surgeons suggests that a traditional, "open" ... for the majority of patients with acute appendicitis, contrary ... are performed in the United States each year to ...
... Feb. 2 Smith & Nephew,s Advanced Wound ... announced that the U.S. Court of Appeals for the Federal ... 1 negative pressure wound therapy system marketed by Blue Sky ... Sky in May 2007."Smith & Nephew welcomes the appeals court ...
... Living: The Financial Options Guide Now Available at Sunrise ... Senior Living (NYSE: SRZ ) now offers ... families identify ideas for affording senior care in today,s ... Living: The Financial Options , is available at Sunrise ...
Cached Medicine News:Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 2Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 3Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 4Health News:Rev Up the Romance this Valentine's Day with Savvy Spa Savings 2Health News:Juva Skin Banishes Bumps with New UniForm Cellulite Therapy Handpiece 2Health News:Treating appendicitis by laparoscopic surgery may not be worth the cost 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 3Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: